Análisis Argos
ACI
ACIBarata · ojo al riesgo1 señal de riesgo
Albertsons Companies, Inc. · Consumer Defensive
US$ 14.13
precio al 2026-07-04
Valor justo Argos*
US$ 19–21
vs. su valor justo
32% por debajo
Score Argos
51/100
Barata · ojo al riesgo
LA RESPUESTA
El mercado la precia para que se encoja 8.3% al año — menos de lo que viene demostrando (2.4%). Un negocio de calidad castigado por expectativas pesimistas: por eso está entre las llamadas de Argos. Ojo: tiene señales de riesgo en sus números — es barata con asterisco.
Recompensas
Cotiza por debajo de su valor justo: el mercado le pide menos crecimiento del que viene demostrando.
Reparte dividendo sostenible (4.39%).
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
!Altman Z'' en zona roja (0.15)
VALOR4/6FUTURO2/6PASADO1/6SALUD1/6DIVIDENDO6/6
El Iris de calidad
VALOR4/6FUTURO2/6PASADO1/6SALUD1/6DIVIDENDO6/6
ValorCotiza por debajo de su valor justo
FuturoCrecimiento moderado
PasadoHistorial débil
SaludBalance frágil
DividendoDevuelve capital al accionista
Score Argos51de 100Barata · ojo al riesgo
Ingresos3%
US$ 83.2 B
Margen operativo53%
0.9%
Flujo de caja libre29%
US$ 0.5 B
Deuda neta
US$ 15.1 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 6.9B
P/E31.8x
EV/EBITDA6.6x
FCF yield7.6%
ROIC3.4%
Margen operativo0.9%
Crecim. ingresos+3.5%/año
Piotroski F5/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 3 jul
Here's Why Albertsons Companies, Inc. (ACI) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
globenewswire.com · 30 jun
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer's Disease
AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer's Disease ACI-24 anti-Abeta active immunotherapy generally safe and well tolerated in first three Alzheimer's disease (AD) cohorts in ABATE Anti-Abeta antibody dose-response demonstrated with antibodies detected at all dose levels in cohorts AD1-3 Ongoing AD4 cohort includes additional adjuvant designed to enhance ACI-24 responses Lausanne, Switzerland, June 30, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced interim data from the first three cohorts (AD1, AD2 & AD3) of 74 patients with prodromal Alzheimer's disease (AD) in the Phase 1b/2 ABATE trial following 12 months of treatment with ACI-24 anti-amyloid beta (Abeta) active immunotherapy. In the trial to date, ACI-24 has been generally safe and well tolerated, with no evidence of amyloid-related imaging abnormalities-edema (ARIA-E).
zacks.com · 29 jun
3 Undervalued Consumer Staples Stocks to Buy for Dividend Income and Defensive Safety
For investors looking to build a defensive hedge within a diversified portfolio, these attractively valued consumer food stocks may deserve a closer look.
pymnts.com · 25 jun
Albertsons Adds Sponsored Product Discovery to AI Grocery Search
Albertsons has launched a new integration with commerce intelligence platform Criteo. The partnership, announced Thursday (June 25) by the grocery giant's retail media arm Albertsons Media Collective, is designed to bring product discovery into Albertsons artificial intelligence-powered conversational search.
fastcompany.com · 24 jun
Walmart, 7-Eleven, Albertsons, and BP used AI to raise gas prices, lawsuit alleges
BP, 7-Eleven, and Walmart are among a slew of gas stations, convenience stores, and big-box retailers that got sued this week for allegedly using artificial intelligence to spike gas prices in California.
zacks.com · 23 jun
Do Options Traders Know Something About ACI Worldwide Stock We Don't?
Investors need to pay close attention to ACIW stock based on the movements in the options market lately.
gurufocus.com · 23 jun
Albertsons Media Collective Brings Sponsored Product Discovery to AI-Powered Conversational Search
[url="]Albertsons Media Collective[/url], the retail media arm for [url="]Albertsons Companies[/url], Inc. (NYSE: ACI), today announced a new integration with
businesswire.com · 23 jun
Albertsons Media Collective Brings Sponsored Product Discovery to AI-Powered Conversational Search
BOISE, Idaho--(BUSINESS WIRE)--Albertsons Media Collective, the retail media arm for Albertsons® Companies, Inc. (NYSE: ACI), today announced a new integration with Criteo (NASDAQ: CRTO), the global commerce intelligence platform, bringing sponsored product discovery into Albertsons Cos.' AI-powered conversational search. The integration enables brands to connect with shoppers as they plan meals, discover products and build baskets.As customers increasingly turn to AI-driven tools for inspiratio.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.